ATE384721T1 - Pyridotriazine und pyridopyridazine - Google Patents
Pyridotriazine und pyridopyridazineInfo
- Publication number
- ATE384721T1 ATE384721T1 AT01122806T AT01122806T ATE384721T1 AT E384721 T1 ATE384721 T1 AT E384721T1 AT 01122806 T AT01122806 T AT 01122806T AT 01122806 T AT01122806 T AT 01122806T AT E384721 T1 ATE384721 T1 AT E384721T1
- Authority
- AT
- Austria
- Prior art keywords
- pyridotriazines
- pyridopyridazines
- restenosis
- angiogenesis
- atherosclerosis
- Prior art date
Links
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Paper (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23760100P | 2000-10-03 | 2000-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384721T1 true ATE384721T1 (de) | 2008-02-15 |
Family
ID=22894409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01122806T ATE384721T1 (de) | 2000-10-03 | 2001-09-22 | Pyridotriazine und pyridopyridazine |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6683183B2 (de) |
| EP (1) | EP1195378B1 (de) |
| JP (1) | JP3541829B2 (de) |
| AT (1) | ATE384721T1 (de) |
| BR (1) | BR0104395A (de) |
| CA (1) | CA2356544C (de) |
| DE (1) | DE60132531T2 (de) |
| ES (1) | ES2296695T3 (de) |
| MX (1) | MXPA01009551A (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076396A2 (en) * | 2001-03-23 | 2002-10-03 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| WO2006045010A2 (en) | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| US8410109B2 (en) | 2005-07-29 | 2013-04-02 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| PT2118074E (pt) | 2007-02-01 | 2014-03-20 | Resverlogix Corp | Compostos para a prevenção e tratamento de doenças cardiovasculares |
| SI2346837T1 (sl) | 2008-06-26 | 2015-05-29 | Resverlogix Corporation | Postopki pripravljanja kinazolinonskih derivatov |
| US8952021B2 (en) | 2009-01-08 | 2015-02-10 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| KR101913109B1 (ko) | 2009-03-18 | 2018-10-31 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| US9757368B2 (en) | 2009-04-22 | 2017-09-12 | Resverlogix Corp. | Anti-inflammatory agents |
| CA2851996C (en) | 2011-11-01 | 2020-01-07 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| LT3495358T (lt) | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| JP2016507496A (ja) | 2012-12-21 | 2016-03-10 | ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． | ブロモドメイン阻害剤としての新規複素環式化合物 |
| CN105294682B (zh) | 2014-07-26 | 2017-07-07 | 广东东阳光药业有限公司 | Cdk类小分子抑制剂的化合物及其用途 |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| US11029951B2 (en) | 2016-08-15 | 2021-06-08 | Micron Technology, Inc. | Smallest or largest value element determination |
-
2001
- 2001-09-06 CA CA002356544A patent/CA2356544C/en not_active Expired - Fee Related
- 2001-09-21 MX MXPA01009551A patent/MXPA01009551A/es not_active Application Discontinuation
- 2001-09-22 EP EP01122806A patent/EP1195378B1/de not_active Expired - Lifetime
- 2001-09-22 AT AT01122806T patent/ATE384721T1/de not_active IP Right Cessation
- 2001-09-22 ES ES01122806T patent/ES2296695T3/es not_active Expired - Lifetime
- 2001-09-22 DE DE60132531T patent/DE60132531T2/de not_active Expired - Fee Related
- 2001-10-02 JP JP2001306029A patent/JP3541829B2/ja not_active Expired - Fee Related
- 2001-10-03 US US09/970,107 patent/US6683183B2/en not_active Expired - Fee Related
- 2001-10-03 BR BR0104395-1A patent/BR0104395A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2356544A1 (en) | 2002-04-03 |
| JP2002121193A (ja) | 2002-04-23 |
| CA2356544C (en) | 2006-04-04 |
| MXPA01009551A (es) | 2002-04-12 |
| ES2296695T3 (es) | 2008-05-01 |
| DE60132531D1 (de) | 2008-03-13 |
| DE60132531T2 (de) | 2009-01-29 |
| EP1195378A1 (de) | 2002-04-10 |
| US20020061865A1 (en) | 2002-05-23 |
| BR0104395A (pt) | 2002-07-09 |
| US6683183B2 (en) | 2004-01-27 |
| JP3541829B2 (ja) | 2004-07-14 |
| EP1195378B1 (de) | 2008-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE384721T1 (de) | Pyridotriazine und pyridopyridazine | |
| NO20026264D0 (no) | Fremgangsmåter for behandling av reumatoid artritt ved anvendelse av opplöselig mutant CTLA4 molekyl | |
| NO972198L (no) | 6-Aryl-pyrido£2,3-d|pyrimidiner og -naftyridiner for inhibering av protein-tyrosin-kinase-bevirket rask cellevekst | |
| DK1769775T3 (da) | Fremgangsmåder og anordning til fremstilling af en intravaskulær stent | |
| ATE237617T1 (de) | Bicyclische pyrimidine derivate und ihre verwendung als antikoagulantien | |
| ATE430742T1 (de) | Pyrimidinamine als angiogenesemodulatoren | |
| EP1156820A4 (de) | Vaskulärer endothelialer wachstumsfaktor 2 | |
| ATE402177T1 (de) | Bicyclische pyrimidine und bicyclische 3,4- dihydropyrimidine als inhibitoren der zellvermehrung | |
| DE60206512D1 (de) | Rapanycin29-enole | |
| ATE490275T1 (de) | Antikörper gegen interleukin-22 und verwendungen dafür | |
| DK1557462T3 (da) | Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse | |
| DE59712873D1 (de) | Halogenpyrimidinylaryl(thio)ether als pestizide | |
| DE69729877D1 (de) | Mycophenol bisphosponatverbindungen | |
| ATE328874T1 (de) | Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren | |
| WO2003073991A3 (en) | Methods to increase or decrease bone density | |
| NO20005153L (no) | Mutantprotein som har lavere allergenisk respons i mennesker og fremgangsmåter for konstruksjon, identifisering og fremstilling av slike proteiner | |
| ATE365165T1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| TR199701669A1 (xx) | Deri preparasyonu i�in bile�imler. | |
| ATE397084T1 (de) | Lentivirale verpackungskonstrukte | |
| IL196900A0 (en) | Autologous t-cell vaccines compositions | |
| DE60235836D1 (de) | Ahren und verwendung davon | |
| WO2003010201A3 (en) | Blood group antigen fusion polypeptides and methods of use thereof | |
| TR200101756T2 (tr) | Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller. | |
| ATE529569T1 (de) | Verfahren zur papierherstellung mit enzymbehandeltem schlamm, und produkte | |
| WO2003000183A3 (en) | Method of treating atherosclerosis and other inflammatory diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |